Only 1 in 18 people with opioid use disorder get effective treatment after overdose

In the week following any hospital visit for an overdose, only 1 in 18 people with opioid use disorder begin a treatment known to be highly effective in reducing illness and deaths, according to new research in CMAJ (Canadian Medical Association Journal).

Opinion | King and Firefighter Syndrome: Disaster Response Goes Beyond the Front Lines

Hawkins is an associate professor of emergency medicine and an emergency medical services specialist. Eldridge is an assistant teaching professor of anthropology. Watson is an

December 24, 2024

Startup Celsius cuts 75% of staff ahead of first trial start for IBD drug

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO

August 3, 2023

Maryland biotech Georgiamune nabs $75M to fund three cancer, autoimmune clinical trials

Maryland biotech Georgiamune emerged Wednesday with a $75 million Series A, clearance to begin its first clinical trial later this year and a board that

August 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.